Structural Basis for the Proinflammatory Cytokine Activity of High Mobility Group Box 1

Jianhua Li(IJ Research (United States)), Riikka Kokkola(Karolinska University Hospital), Siamak Tabibzadeh(Stony Brook Medicine), Runkuan Yang(University of Pittsburgh Medical Center), Mahendar Ochani(IJ Research (United States)), Xiaoling Qiang(IJ Research (United States)), Helena Erlandsson Harris(Karolinska University Hospital), Christopher J. Czura(IJ Research (United States)), Haichao Wang(IJ Research (United States)), Luis Ulloa(IJ Research (United States)), Hong Wang(IJ Research (United States)), H. Shaw Warren(Harvard University), Lyle L. Moldawer(UF Health Shands Hospital), Mitchell P. Fink(University of Pittsburgh Medical Center), Ulf Andersson(Karolinska University Hospital), Kevin J. Tracey(IJ Research (United States)), Huan Yang(IJ Research (United States))
Molecular Medicine
January 1, 2003
Cited by 360Open Access
Full Text

Abstract

High mobility group box 1 (HMGB), a ubiquitous DNA-binding protein, has been implicated as a proinflammatory cytokine and late mediator of lethal endotoxemia. HMGB1 is released by activated macrophages. It amplifies and extends the inflammatory response by inducing cytokine release and mediating acute lung injury, anorexia, and the inflammatory response to tissue necrosis. The kinetics of HMGB1 release provide a wide therapeutic window for endotoxemia because extracellular levels of HMGB1 begin to increase 12 to 24 h after exposure to inflammatory stimuli. Here, we demonstrate that a DNA-binding domain of HMGB1, the B box, recapitulates the cytokine activity of full length HMGB1 and efficiently activates macrophages to release tumor necrosis factor (TNF) and other proinflammatory cytokines. Truncation of the B box revealed that the TNF-stimulating activity localizes to 20 amino acids (HMGB1 amino acids 89 to 108). Passive immunization of mice with antibodies raised against B box conferred significant protection against lethal endotoxemia or sepsis, induced by cecal perforation. These results indicate that a proinflammatory domain of HMGB1 maps to the highly conserved DNA-binding B box, making this primary sequence a suitable target in the design of therapeutics.


Related Papers

No related papers found

Powered by citation graph analysis